Tiny Kidney Protein Could Hold the Key to Fighting Kidney Disease

Scientists have found that a small protein in the kidneys, called R3HDML, plays an important role in keeping kidneys healthy as people age and when disease strikes. The protein is made by special kidney cells called podocytes, which act like tiny filters. Researchers used mice and lab experiments to study what happens when this protein is missing. Their findings suggest that R3HDML could one day be a target for new treatments for kidney disease.

Kidneys are vital organs that clean the blood by filtering out waste and extra fluid. Deep inside the kidney are tiny structures called glomeruli, which act as the main filtering units. Podocytes are cells that wrap around the glomeruli and help control what gets filtered. When podocytes are damaged, the filtering system breaks down, which can lead to serious kidney disease.

The researchers focused on R3HDML, a protein made only by podocytes in the kidney. This protein is released out of podocyte cells into the surrounding space, where it can affect nearby cells. Scientists believe it works by blocking certain enzymes called serine proteases, which can cause harm if left unchecked. Think of R3HDML like a referee that keeps these enzymes from causing too much damage.

To study R3HDML, researchers used a powerful gene-editing tool called CRISPR to create mice that could not make this protein. These mice are called knockout mice because the gene that makes R3HDML was turned off. The mice seemed healthy and normal at first, which showed that losing R3HDML does not cause immediate problems. But things changed as the mice grew older.

When the knockout mice reached 18 months of age — quite old for a mouse — their kidneys started to show problems. The tiny filters in their kidneys had thicker walls and more buildup of material, a process called mesangial expansion. Special electron microscopes showed unusual bumpy deposits forming in the kidney filter's support layer, called the glomerular basement membrane. These changes were not seen in normal mice of the same age.

The researchers also looked at what happens when knockout mice develop diabetes. They gave the mice a drug to cause a type of diabetes similar to Type 1 diabetes in humans. The diabetic knockout mice showed more kidney damage, including more buildup inside the kidney filters, than diabetic mice that still had R3HDML. However, the amount of protein leaking into the urine was not very different between the two groups.

To understand how R3HDML works, scientists looked at all the proteins it interacts with inside cells. They found 173 proteins that R3HDML seems to work alongside, including enzymes that help build collagen, a structural protein found in the kidney filter. One key finding was that R3HDML helps control a signaling system inside cells called p38 MAPK. Signaling systems like this act like a telephone network, passing messages between different parts of a cell.

When R3HDML is present, the p38 MAPK signaling system is quieter and less active. When R3HDML is missing, this system becomes more active, which leads to more collagen building up in the wrong places inside the kidney filter. Too much collagen makes the filter stiff and thick, stopping it from working properly. Blocking the p38 MAPK system with a special drug had the same protective effect as having R3HDML present.

Scientists believe these findings open new doors for treating kidney disease. R3HDML could serve as a biomarker, which is a measurable signal that tells doctors how healthy a kidney is. It could also be a target for new drugs — for example, a synthetic protein that works like R3HDML might treat diabetic kidney disease. More research is needed, but this study gives scientists an important new clue to follow.